AIMA is a women’s health biotech company developing clinically validated, non-hormonal cannabinoid therapeutics for chronic pelvic pain, including endometriosis. Distributed through trusted clinicians, our treatments are supported by an AI-powered Clinical Decision Support Tool that personalizes care. With patents pending and partnerships in the U.S. and Australia, AIMA is redefining pain relief in women’s health.